• A machine learning-based gene signature of response to the novel alkylating agent LP-184 distinguishes its potential tumor indications

    1 month ago - By BMC Bioinformatics

    Non-targeted cytotoxics with anticancer activity are often developed through preclinical stages using response criteria observed in cell lines and xenografts. A panel of the NCI-60 cell lines is frequently the...
    Read more ...